ecopipam
Top stories
Latest
- Teva Pharmaceutical Industries Ltd: Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndromefinanznachrichten.de · 2026-10-02 12:41 UTC · 1 more reports
- Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric PatientsGlobeNewswire — public companies · 2026-10-02 12:00 UTC · 1 more reports